In a report released yesterday, Jasper Hellweg from Argus Research maintained a Buy rating on Novo Nordisk (NVO – Research Report). The ...
GlobalData on MSN15h
FDA beats EMA to most approved new drugs in 2024The FDA has narrowly beaten the European Medicines Agency (EMA) to the most approved drugs with a new active substance in ...
About two and a half years after originating the role of chief commercial officer at Arvinas, John Northcott is leaving his ...
While the deals done this week are important for the future direction of the industry – US company Gilead (US:GILD) inked the biggest, paying up to $1.7bn for Leo Pharma’s range of pre-clinical ...
Pfizer named Dr Chris Boshoff as CSO and president of R&D, effective 1st January 2025. Boshoff, previously Pfizer’s chief ...
Amgen (AMGN) stock in focus as U.S. approval for its lung cancer drug expands for metastatic colorectal cancer. Read more ...
Discover investment opportunities in lesser-covered stocks like Arcus Biosciences, Sarepta Therapeutics, and Edison ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback